Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that a certain test might help find cancer spread in lymph nodes for melanoma patients, but more research is needed due to false positives.

KRTAP2-3 could help predict cancer recurrence by identifying specific cancer cells.

Patients with rapidly progressive alopecia areata often have a better outlook and shorter disease duration, with regrown fine hairs and no past alopecia being positive signs.

Different levels of anti-Müllerian hormone can help diagnose polycystic ovary syndrome in women of different ages.

Skin and hair changes in horses can indicate serious diseases, and recognizing these signs is important for treatment and management.

Nonobese, normotensive Indian women with PCOS may have a higher risk of heart problems linked to inflammation and insulin resistance.

Losing eyelashes or eyebrows can be a sign of many different health problems and needs a careful approach to treat effectively.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

AMH levels are higher in women with PCOS and can indicate the number of small follicles in their ovaries.

Blood vessel patterns in skin diseases relate to certain blood markers in systemic sclerosis but not in psoriasis or psoriatic arthritis, and may indicate circulation issues in alopecia.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Dutasteride may help shrink prostate cancer tumors.

Higher IL-17A levels indicate more severe alopecia areata.

Exclamation mark hairs suggest early scalp disease, while white dots indicate it's chronic.

Genetic marker rs12558842 strongly linked to male hair loss.

DNA methylation changes in women with PCOS could be used as disease markers and suggest new treatment targets.

Certain genetic markers can indicate higher or lower risk for systemic lupus erythematosus.

Markers CRABP1, Nestin, and Ephrin B2 are present in skin cancer environments and may influence their development.

Scalp cooling to prevent hair loss from chemotherapy works for some but not all, and studying hair damage markers could improve prevention and treatment.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

Hirsutism and acanthosis nigricans are reliable skin signs of PCOS linked to metabolic issues, while acne is not a reliable marker of the condition.

Chemotherapy significantly lowers Inhibin A levels in breast cancer patients.

In vivo lineage labelling is better than in vitro methods for identifying and understanding stem cells.

Chronic scalp pain in trichodynia involves both body-wide and localized increased pain sensitivity.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

CAR is a useful marker for assessing alopecia areata severity.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Shorter PSADT after prostate surgery is linked to higher risk of death.

The review found that different stem cell types in the skin are crucial for repair and could help treat skin diseases and cancer.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.